Connor, Clark & Lunn Investment Management (CC&L)
GNMX

Connor, Clark & Lunn Investment Management (CC&L)’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio GNMX Stock Details GNMX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-26,500
Closed -$49K – 1012
2017
Q1 		$49K Buy
+26,500
New +$49K ﹤0.01% 872